A Letter from the President

Dear Friend,

Happy New Year!  I hope 2020 is off to a good start for you!  It sure is for Illinois’ lupus community!  

Our first educational event of the calendar year is THIS SATURDAY!  The Empowering Lupus Patients Educational event is in it’s 13th year.  The purpose of the event is to give participants the tools to live well with lupus.  . This year’s agenda is terrific:

• Hair and Skin Care Facts...When Lupus Shows up; Presented by: Dudley Beauty College Education Team
• Lupus & Hormones; Presented by Dr. Zineb Aouhab, Loyola University Medical Center
• Lupus & Pain Management: Presented by: Dr. Rita McGuire 

For a full agenda and to register click here 

This event is possible for two reasons.  

1. Robertha, Support Group Leader for the Trinity United Church of Christ who has worked on all 13 events. And…
2. The Illinois Lupus Walks.

The Illinois Lupus Walk is a great way to increase lupus awareness in your community.  The Walks are also LSI’s primary fundraiser- enabling us to provide educational events, individual peer support and personal support at no cost to the lupus community.

If you have been to an Illinois Lupus Walk you know how these events honor and celebrate the lupus community.  You don’t have to explain what lupus is to anyone at the lupus walks making it a great way to build your personal lupus network.

We have three Lupus Walks this year – we hope to see you at one. Registration is open now:

• Southern Suburbs, (Chicago Heights) May 2, 2020
• Western Suburbs (Naperville) August 8, 2020
• Chicago – includes a FUN RUN (Lincoln Park) August 30, 2020

We work hard every day to make lives better.  With a staff of 3 and hundreds of volunteers we are able to provide personal support to people who need it.  
Together we make a difference.
Mary Dollear

Quick Links 
Support Group
Past Educational Events
Resources & Support

We've Moved!

Our address is:
411 S. Wells St., Ste. 503
Chicago, IL 60607

Run it  for us!

Sign up here or contact mary@lupusil.org for more information 312-648-6053.

Empowering Lupus Patients Educational Event on Saturday, February 1st!

Join us for our Annual Event on Chicago's South side!

AGENDA
9:30 a.m. - Registration and opening remarks
10:00 a.m. - Hair and Skin Care Facts...When Lupus Shows up
                Presented by: Dudley Beauty College Education Team
11:00 a.m.   Break
11:15 a.m.  Lupus & Hormones: 
                Presented by Dr. Zineb Aouhab, Loyola University Medical Center
12:15 p.m.   Break
12:30 p.m.  Lupus & Pain Management: 
                Presented by: Dr. Rita McGuire 
01:30 p.m.  Closing remarks

At St. Xavier College - 3700 West 103rd St. Chicago, IL 60655
     WAC L203, Butler Reception Room, Chicago, IL 60655

To REGISTER and find out more click here

GSK announces positive headline results in phase 3 study of Benlysta in patients with lupus nephritis

GSK today announced positive headline results for intravenous (IV) Benlysta (belimumab) in the largest controlled phase 3 study in active lupus nephritis (LN), an inflammation of the kidneys caused by systemic lupus erythematosus (SLE) which can lead to end-stage kidney disease.

MORE

We're With You Every Step!

Running the Chicago Marathon?  Join Lupus Charity Runners!  We have an outstanding program that gets you across the finish line WHILE raising awareness about lupus!  Find out more about our team by contacting Mary at mary@lupusil.org or call her at 312-542-0002.

LSI Associate Board Dinner Dance 

Save the date for a great time for a good cause!

April 24, 2020

Fatigue & Lupus

A major problem for people living with lupus is fatigue – chronic debilitating fatigue that significantly decreases quality of life and increases the risk of work disability.

How does someone manage fatigue?  Finding strategies that work for you and for lupus patients in general is the purpose of the Lupus Intervention Fatigue Trial (LIFT).  

RUSH Lupus Study
STUDY OF OMEGA-3 REPLACEMENT WITH KRILL OIL IN TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS

The study is a 24 week randomized, double-blind controlled multicenter study followed by an open label extension treatment for another 24 weeks. The purpose of this study is to determine whether the correction of the omega-3 deficiency may reduce disease activity in SLE patients.